Literature DB >> 8117736

An RNA-binding peptide from bovine immunodeficiency virus Tat protein recognizes an unusual RNA structure.

L Chen1, A D Frankel.   

Abstract

The human immunodeficiency virus (HIV) Tat protein binds specifically to an RNA hairpin, TAR, located at the 5' end of its mRNA. Tat uses a single arginine residue within a short region of basic amino acids to recognize a bulge region in TAR. Here we show that a 17 amino acid arginine-rich peptide from the bovine immunodeficiency virus (BIV) Tat protein also binds to an RNA hairpin at the 5' end of its mRNA (BIV TAR), but recognizes different structural features of the RNA. Mutagenesis, RNase mapping, and chemical interference experiments indicate that bulge and stem regions of BIV TAR are recognized simultaneously by the BIV peptide and that the RNA adopts an unusual structure. BIV Tat binds to its TAR site with high affinity and specificity and, unlike HIV Tat, does not appear to use cellular proteins to stabilize RNA binding in vivo. Thus, two related viral activators have evolved rather distinct ways to recognize their RNA targets.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8117736     DOI: 10.1021/bi00175a046

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

1.  Structure and function of the PWI motif: a novel nucleic acid-binding domain that facilitates pre-mRNA processing.

Authors:  Blair R Szymczyna; John Bowman; Susan McCracken; Antonio Pineda-Lucena; Ying Lu; Brian Cox; Mark Lambermon; Brenton R Graveley; Cheryl H Arrowsmith; Benjamin J Blencowe
Journal:  Genes Dev       Date:  2003-02-15       Impact factor: 11.361

2.  A ribozyme that ligates RNA to protein.

Authors:  Scott Baskerville; David P Bartel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-20       Impact factor: 11.205

3.  Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.

Authors:  Baode Xie; Valerie Calabro; Mark A Wainberg; Alan D Frankel
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

4.  Selection of RRE RNA binding peptides using a kanamycin antitermination assay.

Authors:  Hadas Peled-Zehavi; Satoru Horiya; Chandreyee Das; Kazuo Harada; Alan D Frankel
Journal:  RNA       Date:  2003-02       Impact factor: 4.942

5.  Evolvability of the mode of peptide binding by an RNA.

Authors:  Tetsuya Iwazaki; Xianglan Li; Kazuo Harada
Journal:  RNA       Date:  2005-07-25       Impact factor: 4.942

6.  Molding a peptide into an RNA site by in vivo peptide evolution.

Authors:  K Harada; S S Martin; R Tan; A D Frankel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

7.  A novel glutamine-RNA interaction identified by screening libraries in mammalian cells.

Authors:  R Tan; A D Frankel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

8.  RNA base-amino acid interaction strengths derived from structures and sequences.

Authors:  B Lustig; S Arora; R L Jernigan
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

9.  Analysis of bacteriophage N protein and peptide binding to boxB RNA using polyacrylamide gel coelectrophoresis (PACE).

Authors:  C D Cilley; J R Williamson
Journal:  RNA       Date:  1997-01       Impact factor: 4.942

Review 10.  Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery.

Authors:  Sai Shashank Chavali; Rachel Bonn-Breach; Joseph E Wedekind
Journal:  J Biol Chem       Date:  2019-05-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.